Response to Bergmann et al: Carbon 14 Birth Dating of Human Cardiomyocytes
The letter by Bergmann and collaborators 1 questions our comments 2 regarding their work on 14 C birth dating of human cardiomyocytes with aging. 3 Three points are made in an attempt to challenge the issues we have raised, which cast serious doubts on the validity of their data on myocyte turnover with physiological aging: (1) appropriateness of the myocardial samples examined; (2) specificity of the protocol used for the isolation of myocyte nuclei; and (3) correct interpretation of the 14 C measurements.
Myocardial Samples
As acknowledged in their letter, 6 of the 12 hearts studied, that is, 50% of the cases, had overt myocardial pathology. Surprisingly, samples collected from a patient who died of acute myocardial infarction were considered representative of normal cardiac aging. Additionally, no histological analysis was performed in the 6 "nonpathological" hearts; gross examination at autopsy was deemed to be sufficient to define the structural integrity of the myocardium. Specific clinical, anatomic, and histological criteria have to be met for the inclusion of human hearts in studies of physiological aging (Table) . 4, 5 The approach used by Bergmann and collaborators is far from any sensible standard needed to determine the biology of human cardiac aging.
Isolation of Myocyte Nuclei
The authors defend the findings reported in Science 3 by citing the article that subsequently appeared in Experimental Cell Research. 6 We have been criticized in the letter for ignoring this hastily published report. Our reasons for not quoting this second report must be discussed. In this work, a series of images illustrating different degrees of nuclear troponin staining have been obtained with a variety of antigen retrieval methods. These findings have been interpreted as unequivocal documentation of the expression of troponin I in myocyte nuclei, independent from the age of the cells, rather than the consequence of alterations in nuclear pore complexes in senescent cardiomyocytes with nuclear translocation of proteins physiologically restricted to the cytoplasm. 7 However, all these stainings were done in formalinfixed, paraffin-embedded tissue. These protocols do not correspond to the preparation of unfixed nuclei that was used in the article in Science. 3 Importantly, controls for specificity of the staining for cardiac troponin T and troponin I were not performed in this 6 and in the previous study. 3 The conviction of the authors that mixing antibodies with donkey serum "prevents nonspecific antibody reactions" is questionable. 6 This approach may decrease the unspecific binding of the secondary antibody generated in donkeys, but it will not prevent the unspecific interaction of the primary antibody with nuclear proteins. Controls with omission of the primary antibody, irrelevant primary antibody and immunoprecipitation of primary antibody with troponin proteins were not performed. Similarly, spectral analysis to confirm the specificity of the recorded signals was not introduced. These limitations apply also to labeling of the pericentriolar material-1 protein used to identify myocyte nuclei. 6 Conversely, all these controls were done in our study 7 that questioned the validity of troponin expression in young, intact cardiomyocyte nuclei.
Troponin I-Positive Myocyte Nuclei
The data in Figure 2 of the article published in Experimental Cell Research are misleading. 6 Myocyte number decreases with age, whereas the number of fibroblasts increases. Interstitial fibrosis and foci of replacement fibrosis are typically found in the aged human heart, 4, 5, 8 and comparable findings have been reported in rats and mice. 9, 10 This is highly relevant because the analysis of 14 C was performed in 6 old, diseased hearts 3 in which myocardial scarring was a critical factor. Unfortunately, this variable was not introduced by Bergmann and collaborators, making their analysis invalid. By measuring only the percentage of troponin I-positive myocyte nuclei without considering the increase in fibroblasts, their data are consistent with the notion that the percentage of troponin I-positive myocyte nuclei increases with age. 7 Relative measurements cannot be directly translated into absolute values. 11
Nuclear DNA Content
The 3-dimensional reconstruction illustrating the procedure used to measure DNA content in myocardial sections 30 m in thickness is problematic. 6 By necessity, the intensity of labeling of nuclei varied across the thickness of the section, becoming progressively weaker with the depth of the section. To compensate for this artifact, the signal intensity of the labeled DNA was amplified to levels saturating the photodetection system. This is apparent in the images shown in Figure 4 (Bergmann et al 6 ). As a result, all nuclei had comparable brightness, and the major variable was represented by the size of the nucleus rather than by the actual DNA content. This makes the measurement of ploidy invalid. 7
Mathematical Model
The atmospheric 14 C curve ( Figure 1A) shows the dependent variable, 14 C concentration, as a function of time, which reflects the independent variable. This curve has the characteristics of a proper function: one independent variable yields one and only one dependent variable. However, in retrospective 14 C birth dating of cells, 14 C is used as the independent variable and time as the dependent variable ( Figure 1B) . This transformation produces a degenerate function, that is, one independent variable yields more than one dependent variables. This fundamental principle has been overlooked in the analysis and interpretation of the data on 14 C in myocyte nuclei. 3 An arbitrary decision was made and the ascending limb of the 14 C curve was used to derive myocyte age in individuals born before the atmospheric 14 C peak. There is no basis for this predetermined biased choice. No additional information concerning myocyte renewal in these samples was obtained to support this approach. If the descending limb of the 14 C curve would have been considered, myocyte turnover rate would have been higher with aging, a phenomenon shown recently to be the case. 5 The 12 mathematical scenarios listed in the online material 3 are irrelevant when this critical variable is not resolved. Additionally, the exponential decay curve drawn arbitrarily to fit the data is statistically incorrect. 2, 7 Nonmyocyte Birth Date: 1000 AD Some comments concerning the analysis of the results on atmospheric 14 C are in order. Figure 2A ( Figure 1C in Reference 2) illustrates the data obtained from patients 50 -73 years of age. In these hearts, it is not possible to indicate the age of the cells because the measured 14 C may reflect its incorporation during the rising or decaying part of the 14 C curve (indicated by us with red ovals). The difference in the rate of myocyte renewal between young and old individuals may reflect an artifact in calculation due to assumptions of the model imposed and not a real biological phenomenon. Let us consider the patient shown by the green line in Figure 2A . If this subject had 2 bursts of myocyte formation, 1 in 1958 and 1 in 1997, identical values of 14 C content would be obtained and incorrectly interpreted as reflecting myocytes born only in 1958. Also, the heart of the 4 oldest patients, born between 1939 and 1955 (bracket), could contain myocytes born before the sharp rise of atmospheric 14 C, or myocytes formed shortly before death. In the original graph, the black line of the 14 C curve was not drawn to the time of the patient's death, late 2006/early 2007; this missing part is now shown in blue (arrow). Thus, the claim that myocyte renewal decreases with age has no basis.
Despite the attempt made to defend the data published in Science, to fit the model, 3 of the 6 subjects born after the 14 C peak (Panel B: vertical lines within bracket) required nonmyocytes to possess impossible 14 C signatures from before the bomb pulse ( Figure 2B, green dots) . Importantly, the subject born before the bomb pulse, shown by a green line in Figure 2A and by a yellow dot in Figure 2B , required nonmyocyte DNA from The age of cardiomyocytes in these cases can be derived from both the ascending and the descending limb of the 14 C curve (red ovals). This is the consequence of the degenerate function shown in Figure 1B . Thus, the average age of cardiomyocytes in these 5 hearts can be old (ascending limb) or very young (descending limb). B, The birth date of noncardiomyocytes was not directly measured by 14 C concentration but was computed from the levels of 14 C in cardiomyocytes and in the left ventricular myocardium. By this approach, the average age of noncardiomyocytes (green circles) was computed to be older than the age of the individuals involved (vertical lines). An extreme case is shown by the yellow circle that indicates that the average age of noncardiomyocytes in this sample was 1000 years. Table S1 of the online material. 3 Even if we accept the ⌬ 14 C 42.76 value, noncardiomyocytes and cardiomyocytes would be of comparable age, 48 and 49 years old, respectively, sharply in contrast with the 18-to 40-fold higher turnover rate claimed by the authors for noncardiomyocytes. 3 Finally, the fraction of cardiomyocytes used in the original study 2 varied from 29% to 60% of the cardiac cell pool (Table 3 online), confirming the lack of specificity of the nuclear markers used to collect myocyte nuclei. The 36% value indicated in the letter refers to the report in Experimental Cell Research, 6 which has no relevance to retrospective 14 C birth dating of human cardiomyocytes.
Conclusions
Unfortunately, the findings on myocyte turnover reported in Science in 2009 support the old view of the limited regenerative capacity of the adult and aging human heart. These results have often been used to challenge the notion that the heart is a self-renewing organ regulated by a stem cell compartment. Editorials 12,13 and reviews 14, 15 have taken this information to question the existence of a resident stem cell and its critical role in cardiac homeostasis and pathology. Importantly, new clinical data are emerging in which cardiac stem cells have been isolated from very sick hearts, expanded in vitro, and delivered back to the patients. 16 The dramatic improvement in quality of life and cardiac performance offers the most compelling argument in favor of the regenerative capacity of the adult diseased human heart. 
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